NRX Pharmaceuticals, Inc. NRXP
NASDAQ · United States · Health Technology
$2.85-0.07 (-2.40%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-17 | -0.44 | -0.11 | -312.5% | $1.10M | -17.2% | +5.2%$3.27→$3.44 |
| Q1 2026 | 2026-05-15 | -0.04 | -0.11 | +63.6% | — | — | -3.0%$3.21→$3.12 |
| Q4 2025 | 2026-03-23 | 0.18 | -0.08 | +325.0% | — | — | +15.1%$1.85→$2.13 |
| Q3 2025 | 2025-11-14 | -0.51 | -0.02 | -2,450.0% | — | — | -18.5%$2.59→$2.11 |
| Q2 2025 | 2025-08-18 | -0.98 | -0.23 | -326.1% | — | — | — |
| Q1 2025 | 2025-05-15 | -0.34 | -0.25 | -36.0% | — | — | — |
| Q4 2024 | 2025-03-14 | -0.77 | -0.37 | -108.1% | — | — | — |
| Q3 2024 | 2024-11-14 | -0.15 | -0.66 | +77.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.